Article Abstract

MicroRNA-122 in patients with hepatitis B and hepatitis B virusassociated hepatocellular carcinoma

Authors: Mohammad Reza Mahmoudian-Sani, Samira Asgharzade, Arash Alghasi, Ali Saeedi-Boroujeni, Seyed Jafar Adnani Sadati, Mohammad Taghi Moradi


Hepatitis B virus (HBV) infection is known as a serious problem in the domain of public health and approximately 350 million people across the world are affected with this infectious disease. As well, microRNAs are recognized as a type of small non-coding RNAs that can be widely used as a diagnostic biomarker and prognosis method of special diseases. In this respect, microRNA-122 or miR-122 can play a significant role in the pathogenesis of several hepatic diseases. Given the importance of microRNA-122 in the liver as well as its pathology, this study focused on the potential functions of microRNA-122 in pathogenesis, diagnosis, and treatment of HBV infection. In this regard, the findings of previous studies had indicated that expression of microRNA-122 in patients with HBV infection could be significantly deregulated. The results of this study were consistent with the idea that diagnosis and treatment of this infectious disease using microRNA-122 could be an efficient method.

Article Options

Download Citation